Literature DB >> 15229321

Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity.

Jeffrey M Beekman1, Jantine E Bakema, Jan G J van de Winkel, Jeanette H W Leusen.   

Abstract

FcgammaRI depends for its biological function on both the intracellular domain of the alpha-chain and associated Fc receptor (FcR) gamma-chains. However, functional protein effectors of FcgammaRI's intracellular domain have not been identified. In this study, we identified periplakin (PPL) as a selective interacting protein for the intracellular tail of FcgammaRI but no other activatory FcRs. The interaction was confirmed by coimmunoprecipitation and blot-overlay assays. PPL and FcgammaRI colocalized at the plasma membrane in monocytes and cell transfectants, and both were up-regulated by IFN-gamma. By expressing C-terminal PPL in transfectants, we established a pivotal role for this protein in FcgammaRI ligand binding, endocytosis, and antigen presentation. These data illustrate that intracellular protein interactions with a multisubunit FcR alpha-chain can confer unique properties to the receptor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15229321      PMCID: PMC478582          DOI: 10.1073/pnas.0401217101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Biology of human immunoglobulin G Fc receptors.

Authors:  J G van de Winkel; C L Anderson
Journal:  J Leukoc Biol       Date:  1991-05       Impact factor: 4.962

2.  Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia.

Authors:  P M Steinert; L N Marekov
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

3.  Interactions between the cytosolic components p47phox and p67phox of the human neutrophil NADPH oxidase that are not required for activation in the cell-free system.

Authors:  J H Leusen; K Fluiter; P M Hilarius; D Roos; A J Verhoeven; B G Bolscher
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

4.  A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeutics.

Authors:  I A Heijnen; J G Van de Winkel
Journal:  J Hematother       Date:  1995-10

5.  Functional differences between two Fc receptor ITAM signaling motifs.

Authors:  I E Van den Herik-Oudijk; M W Ter Bekke; M J Tempelman; P J Capel; J G Van de Winkel
Journal:  Blood       Date:  1995-11-01       Impact factor: 22.113

6.  Protein tyrosine kinase activity is essential for Fc gamma receptor-mediated intracellular killing of Staphylococcus aureus by human monocytes.

Authors:  L Zheng; P H Nibbering; T P Zomerdijk; R van Furth
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.

Authors:  I A Heijnen; M J van Vugt; N A Fanger; R F Graziano; T P de Wit; F M Hofhuis; P M Guyre; P J Capel; J S Verbeek; J G van de Winkel
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

Review 8.  Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications.

Authors:  J G van de Winkel; P J Capel
Journal:  Immunol Today       Date:  1993-05

9.  Protein-tyrosine kinase p72syk in Fc gamma RI receptor signaling.

Authors:  D L Durden; Y B Liu
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

10.  Ligand-sensitive binding of actin-binding protein to immunoglobulin G Fc receptor I (Fc gamma RI).

Authors:  Y Ohta; T P Stossel; J H Hartwig
Journal:  Cell       Date:  1991-10-18       Impact factor: 41.582

View more
  15 in total

1.  Serine phosphorylation of FcγRI cytoplasmic domain directs lipid raft localization and interaction with protein 4.1G.

Authors:  Andrew W Gibson; Xinrui Li; Jianming Wu; Julie G Baskin; Chander Raman; Jeffrey C Edberg; Robert P Kimberly
Journal:  J Leukoc Biol       Date:  2011-10-14       Impact factor: 4.962

2.  Identification of periplakin as a major regulator of lung injury and repair in mice.

Authors:  Valérie Besnard; Rania Dagher; Tania Madjer; Audrey Joannes; Madeleine Jaillet; Martin Kolb; Philippe Bonniaud; Lynne A Murray; Matthew A Sleeman; Bruno Crestani
Journal:  JCI Insight       Date:  2018-03-08

3.  Divergent intracellular sorting of Fc{gamma}RIIA and Fc{gamma}RIIB2.

Authors:  Christine Y Zhang; James W Booth
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

4.  Prognostic implications of PPL expression in ovarian cancer.

Authors:  Tian Hua; Bei-Bei Zhao; Shao-Bei Fan; Cai-Fen Zhao; Yun-Hong Kong; Rui-Qing Tian; Bao-Ying Zhang
Journal:  Discov Oncol       Date:  2022-05-25

Review 5.  Cross-presentation of IgG-containing immune complexes.

Authors:  Kristi Baker; Timo Rath; Wayne I Lencer; Edda Fiebiger; Richard S Blumberg
Journal:  Cell Mol Life Sci       Date:  2012-07-31       Impact factor: 9.261

6.  Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.

Authors:  Rahul Mittal; Sunil K Sukumaran; Suresh K Selvaraj; David G Wooster; M Madan Babu; Alan D Schreiber; J Sjef Verbeek; Nemani V Prasadarao
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

Review 7.  Fc-receptors and immunity to malaria: from models to vaccines.

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

8.  B-cells get the T-cells but antibodies get the worms.

Authors:  Richard J Pleass; Jerzy M Behnke
Journal:  Trends Parasitol       Date:  2009-09-04

Review 9.  The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence.

Authors:  Tamsin Wesley; Stuart Berzins; George Kannourakis; Nuzhat Ahmed
Journal:  Cell Commun Signal       Date:  2021-05-17       Impact factor: 5.712

10.  Cholestasis induces reversible accumulation of periplakin in mouse liver.

Authors:  Shinji Ito; Junko Satoh; Tsutomu Matsubara; Yatrik M Shah; Sung-hoon Ahn; Cherie R Anderson; Weiwei Shan; Jeffrey M Peters; Frank J Gonzalez
Journal:  BMC Gastroenterol       Date:  2013-07-13       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.